Jose Cayasso

Part of Corporación BCT SA, Banco BCT SA is a banking institution based in San Jose, Costa Rica. In response to the government's emergency declaration, the bank has modified its schedule of care for its agencies, with special hours for older adults. The bank also offers digital service channels, including BCT Link, an online bank for account management, payment of services, and transfers. The bank provides an exchange rate of ¢543.00 for buying and ¢561.00 for selling. For more information, clients can contact the bank through their website or email. Founded in 1983, the bank prioritizes the well-being of its clients, collaborators, and commercial partners.

Carao Ventures (Carao Ventures) is a venture capital firm founded in 2012 by Allan Boruchowicz and Adrián García. The firm has headquarters in San Jose, CR.

Singular Me Corp. builds scalable machine learning and deduction engine that uses the latest data science and big data algorithms in order to generate content and conditional rules that capture customers behaviors and beliefs. The company was founded by Carlos Araya and Marco Astua in 2012 and is headquartered in Saratoga, CA.

Speratum CR SA operates as a medical research company. It provides treatment for the patients suffering from pancreatic cancer. The firm combines nanotechnology and microRNA-based therapeutics to fight cancer. Its technology helps in reducing pancreatic cancer aggressiveness, reducing tumour spread and metastasis. The company was founded by Christian Marin-Müller in 2014 and is headquartered in San Jose, Costa Rica.

Hulihealth Costa Rica SRL provides a multiservice web platform that connects patients with doctors and health specialists. The company is based in Curridabat, Costa Rica. The Costa Rican company was founded in 2012 by Alejandro Vega, who has been the CEO since 2012.

BildTek SA is a Costa Rican company that specializes in creating custom cold-formed steel solutions for cost-effective and top-grade structures with fast deployment. The company's design flexibility ensures that the architect's vision is always fulfilled. Federico Amador has been the CEO of the company since 2013.

Speratum Biopharma, Inc. is a pre-clinical stage biotechnology company based in Dover, DE. Speratum is focused on the research and development of targeted molecular therapeutics for the treatment of cancer. The company's primary focus is developing a multi-component therapeutic against multiple cancer types that includes a proprietary RNA interference (RNAi)-inducing mimic of mir-198, a naturally occurring microRNA involved in the pathogenesis of several solid cancers, combined with a novel biocompatible material suitable for systemic and targeted delivery of nucleic acids. Speratum's platforms for drug delivery and oligonucleotide administration have broad application potential, and have been out-licensed for multiple therapeutic and research modalities. The company was founded by Christian Marín-Müller, who has been the CEO since incorporation.